Literature DB >> 10888113

Differential nuclear localization of the IFNGR-1 and IFNGR-2 subunits of the IFN-gamma receptor complex following activation by IFN-gamma.

J Larkin1, H M Johnson, P S Subramaniam.   

Abstract

We have recently identified a nuclear localization sequence (NLS) in the C-terminus of murine type II interferon (IFN), IFN-gamma, that is responsible for the internalization and nuclear translocation of extracellularly added IFN-gamma. Because the uptake of IFN-gamma is a receptor-mediated endocytotic process, we examined in this study the fate of both the receptor subunits (IFNGR-1 and IFNGR-2) of the heterodimeric IFN-gamma receptor complex. Human IFN-gamma (HuIFN-gamma) was also found to contain a polybasic NLS in a conserved C-terminal region capable of directing its nuclear translocation. Like the ligand, the IFNGR-1 subunit of the receptor complex on WISH cells was found to be translocated to the nucleus on treatment with HuIFN-gamma. Using a combination of immunoprecipitation and immunofluorescence techniques, we found the nuclear accumulation of IFNGR-1 to be ligand dependent, and it was evident within 10-20 min after ligand stimulation. IFNGR-1 was found to colocalize, in a time-dependent and dose-dependent fashion, with the nuclear translocation of the transcription factor Stat1alpha, which is activated by this ligand-receptor system. In addition, Stat1alpha was found to be complexed with IFNGR-1 over the time period of its nuclear translocation. In marked contrast, IFNGR-2 was not transported to the nucleus. The surface immunofluorescence pattern of IFNGR-2 suggested that, following ligand stimulation, the majority of IFNGR-2 remains at the cell surface, whereas IFNGR-1 is endocytosed and targeted to the cell nucleus. These findings suggest that IFNGR-1 plays an active intracellular role in signal transduction events subsequent to the binding of ligand to the dimeric receptor complex. Furthermore, these studies provide the first example of the selective endocytosis and nuclear translocation of a subunit of a multimeric receptor complex.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10888113     DOI: 10.1089/10799900050044769

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  21 in total

1.  Efficacy of leukemia inhibitory factor as a therapeutic for permanent large vessel stroke differs among aged male and female rats.

Authors:  Stephanie M Davis; Lisa A Collier; Sarah Goodwin; Douglas E Lukins; David K Powell; Keith R Pennypacker
Journal:  Brain Res       Date:  2018-11-13       Impact factor: 3.252

Review 2.  Steroid-like signalling by interferons: making sense of specific gene activation by cytokines.

Authors:  Howard M Johnson; Ezra N Noon-Song; Kaisa Kemppainen; Chulbul M Ahmed
Journal:  Biochem J       Date:  2012-04-15       Impact factor: 3.857

Review 3.  Trafficking of receptor tyrosine kinases to the nucleus.

Authors:  Graham Carpenter; Hong-Jun Liao
Journal:  Exp Cell Res       Date:  2008-10-11       Impact factor: 3.905

Review 4.  Beyond autophagy: New roles for ULK1 in immune signaling and interferon responses.

Authors:  Diana Saleiro; Ewa M Kosciuczuk; Leonidas C Platanias
Journal:  Cytokine Growth Factor Rev       Date:  2016-04-01       Impact factor: 7.638

5.  CD4-expressing cells are early mediators of the innate immune system during sepsis.

Authors:  André Martignoni; Johannes Tschöp; Holly S Goetzman; Lisa G Choi; Maria D Reid; Jay A Johannigman; Alex B Lentsch; Charles C Caldwell
Journal:  Shock       Date:  2008-05       Impact factor: 3.454

6.  Controlling Nuclear Jaks and Stats for Specific Gene Activation by Ifn γ and Other Cytokines: A Possible Steroid-like Connection.

Authors:  Howard M Johnson; Ezra Noon-Song; Chulbul M Ahmed
Journal:  J Clin Cell Immunol       Date:  2011-09-03

7.  Keratinocyte-Derived Chemokines Orchestrate T-Cell Positioning in the Epidermis during Vitiligo and May Serve as Biomarkers of Disease.

Authors:  Jillian M Richmond; Dinesh S Bangari; Kingsley I Essien; Sharif D Currimbhoy; Joanna R Groom; Amit G Pandya; Michele E Youd; Andrew D Luster; John E Harris
Journal:  J Invest Dermatol       Date:  2016-09-26       Impact factor: 8.551

8.  Post-translational modification of the interferon-gamma receptor alters its stability and signaling.

Authors:  James D Londino; Dexter L Gulick; Travis B Lear; Tomeka L Suber; Nathaniel M Weathington; Luke S Masa; Bill B Chen; Rama K Mallampalli
Journal:  Biochem J       Date:  2017-10-10       Impact factor: 3.857

9.  Tumor escape and progression of HER-2/neu negative breast cancer under immune pressure.

Authors:  Maciej Kmieciak; Kyle K Payne; Michael O Idowu; Margaret M Grimes; Laura Graham; Maria-Libera Ascierto; Ena Wang; Xiang-Yang Wang; Harry D Bear; Masoud H Manjili
Journal:  J Transl Med       Date:  2011-03-31       Impact factor: 5.531

Review 10.  Interferon-γ: teammate or opponent in the tumour microenvironment?

Authors:  Angela M Gocher; Creg J Workman; Dario A A Vignali
Journal:  Nat Rev Immunol       Date:  2021-06-21       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.